AU2003214072A8 - Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) - Google Patents
Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)Info
- Publication number
- AU2003214072A8 AU2003214072A8 AU2003214072A AU2003214072A AU2003214072A8 AU 2003214072 A8 AU2003214072 A8 AU 2003214072A8 AU 2003214072 A AU2003214072 A AU 2003214072A AU 2003214072 A AU2003214072 A AU 2003214072A AU 2003214072 A8 AU2003214072 A8 AU 2003214072A8
- Authority
- AU
- Australia
- Prior art keywords
- fpr
- therapeutics
- diagnostics
- diseases associated
- peptide receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02005202 | 2002-03-07 | ||
EP02005202.3 | 2002-03-07 | ||
PCT/EP2003/001838 WO2003074069A2 (en) | 2002-03-07 | 2003-02-24 | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003214072A8 true AU2003214072A8 (en) | 2003-09-16 |
AU2003214072A1 AU2003214072A1 (en) | 2003-09-16 |
Family
ID=27771845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003214072A Abandoned AU2003214072A1 (en) | 2002-03-07 | 2003-02-24 | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003214072A1 (en) |
WO (1) | WO2003074069A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003267347A1 (en) * | 2003-09-10 | 2005-03-29 | Galapagos Genomics N.V. | Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell |
EP1692502A2 (en) * | 2003-11-07 | 2006-08-23 | Acadia Pharmaceuticals Inc. | Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
US7659091B2 (en) | 2004-09-21 | 2010-02-09 | Nourheart, Inc. | Diagnostic marker |
US7662571B2 (en) | 2005-07-14 | 2010-02-16 | Nourheart Inc. | Mitochondrial markers of ischemia |
US20080008694A1 (en) | 2006-07-05 | 2008-01-10 | Elgebaly Salwa A | Methods to prevent and treat diseases |
EP2490021A1 (en) * | 2011-02-18 | 2012-08-22 | Biotempt B.V. | Modulators of PRR and GPCR signalling |
HUE047739T2 (en) * | 2012-01-06 | 2020-05-28 | Viomics Inc | System and method of detecting rnas altered by lung cancer in peripheral blood |
WO2016123672A1 (en) * | 2015-02-04 | 2016-08-11 | Baker Idi Heart & Diabetes Institute Holdings Limited | A method of treatment and compounds for use therein |
WO2019212305A1 (en) * | 2018-05-04 | 2019-11-07 | 사회복지법인 삼성생명공익재단 | Screening method for therapeutic substance for preventing or treating bronchopulmonary dysplasia (bpd) |
KR102173673B1 (en) * | 2018-05-04 | 2020-11-03 | 사회복지법인 삼성생명공익재단 | Method for screening substances for the prevention or treatment of bronchopulmonary dysplasia (BPD) |
CN115317611B (en) * | 2022-07-05 | 2023-07-28 | 天津天海新域生物科技有限公司 | Use of FPR1 antagonist T-0080 for preparing medicine for treating atherosclerosis |
-
2003
- 2003-02-24 WO PCT/EP2003/001838 patent/WO2003074069A2/en not_active Application Discontinuation
- 2003-02-24 AU AU2003214072A patent/AU2003214072A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003074069A2 (en) | 2003-09-12 |
WO2003074069A3 (en) | 2004-04-01 |
AU2003214072A1 (en) | 2003-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003214249A8 (en) | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) | |
AU2003214072A8 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
AU2003229735A8 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
AU2003239819A1 (en) | Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2) | |
AU2003229767A8 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
AU2003273994A8 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
AU2003240589A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4) | |
AU2003240721A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4) | |
AU2003206749A1 (en) | Diagnostics and therapeutics for diseases associated with the gpr65 receptor | |
AU2003216866A8 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) | |
AU2003250128A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) | |
AU2003229736A1 (en) | Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) | |
AU2003227751A1 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1) | |
AU2003240639A1 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) | |
AU2003276106A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) | |
AU2003238174A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 3 (sstr3) | |
AU2003229753A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
AU2003221502A8 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10) | |
AU2003218638A8 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
AU2003301892A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) | |
AU2003240736A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 2 (sstr2) | |
AU2003227064A8 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) | |
AU2003274005A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6) | |
AU2003246726A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45) | |
AU2003276097A8 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |